BAP1 and colonic neoplasm: Immunohistochemical staining data from the Human Protein Atlas showed that 100% and 55% of examined colon cancer patients exhibited high and medium BAP1 expression levels, respectively, depending on the source of the antibodies used (Fig. 1A).